AU markets
Biotech and healthcare company research across the US and Australia, covering drug development, medical devices, diagnostics and healthcare businesses. Explore articles on clinical milestones, regulatory announcements, commercial progress and financing. Coverage considers the distinction between a research milestone and an approved or commercially established product, alongside the risks and remaining steps described in each dated article.
21 results
Explore United States marketsAustralia · Company Research
4DMedical (ASX: 4DX) shares crashed on Friday, 17 July 2026, despite the medical-imaging company announcing potentially positive news from the United States. The 4DMedical share price closed…
Australia · Company Research
The Mesoblast (ASX: MSB) share price rose 6.67% on Friday, 10 July 2026, gaining 14 cents to close at A$2.24. The stock also gained approximately 9.3% across the…
Australia · Company Research
Echo IQ Limited (ASX:EIQ) has moved into the second camp. The company’s latest announcement, a binding heads of agreement with Pro Medicus Limited, landed on 25 June 2026…
Australia · Company Research
Zoono Group (ASX:ZNO) is no longer just asking investors to think about antimicrobial sprays, wipes and surface protection. The company is trying to make food packaging the main…
Australia · Company Research
The hard part with small-cap biotech is that the story can sound compelling long before the evidence catches up. Avecho Biotechnology Ltd (ASX:AVE) has spent the past two…
Australia · Company Research
For years, CSL Limited (ASX:CSL) enjoyed the rarest status on the ASX: a growth company that also felt defensive. Plasma, vaccines, rare diseases, global scale, high barriers to…
Australia · Company Research
BCAL Diagnostics (ASX:BDX) is no longer telling a one-test story. For years, the company’s centre of gravity was BREASTESTplus, a non-invasive blood test designed to support breast cancer…
Australia · Company Research
The interesting part of TALi Digital Limited (ASX:TD1) is no longer just the attention-training software that gave the company its name. It is the second act. In its…
Australia · Company Research
Sigma Healthcare (ASX:SIG) shares rose sharply after the company walked away from talks to buy UK pharmacy chain Boots. The stock traded around A$2.80, up 6.06% at the…
Australia · Company Research
Beamtree Holdings Ltd (ASX:BMT) announced on 5 May 2026 that it had secured an A$2m contract with Fakeeh Care Group in Saudi Arabia. The deal runs for 12…
Australia · Company Research
The awkward part of a trading resumption is that the market gets to speak first. Microba Life Sciences Ltd (ASX:MAP) returned to trade with a weaker tone, falling…
Australia · Company Research
A fall from A$0.044 to A$0.040 does not sound like much until the percentage does the talking. Immuron Limited (ASX:IMC) is down 9.09% from the open, based on…
